De melding van bijwerkingen zou worden vereenvoudigd en de bedrijven-vergunninghouders zouden minder maar relevantere "periodic safety updated reports" (PSUR's) moeten opstellen.
Adverse reaction reporting would be simplified, resulting in fewer, more relevant periodic safety updated reports (PSURs) being prepared by firms which are marketing authorisation holders.